The size of the inoculum has, within certain wide limits, no effect upon the attack rate, duration of the incubation period or severity of the illness. The agent has been detected circulating in the blood of one recipient thirty-four days after inoculation and 60 days before the appearance of jaundice and in another recipient seven days after the appearance of jaundice, but not two months later. A single specimen of serum collected on the seventh day of jaundice from a presumedly induced case produced hepatitis and jaundice when injected intranasally, though the original pool used as inoculum did not. Transmission of the disease to man by intranasal inoculation of nasopharyngeal washings collected in the pre-icteric and early icteric stages has been reported in West Africa by Findlay and Martin. This is a contradiction of the results obtained by intranasal injection of icterogenic serum pools, but the difference may be related to the state in which the agent is present in the pools. (No successful transmissions with nasopharyngeal washings from cases of naturally occurring infective hepatitis have been recorded.) It has not been possible to transmit the disease by oral administration of facces from cases induced by the injection of icterogenic pools. All the results of the experimental inoculation by different routes of serum and other excreta servs to distinguish the usual form of homologous serum hepatitis from natuially occurring infective hepatitis.
The reinoculation, accidentally or experimentally, of individuals convalescent from either homologous serum hepatitis or infective hepatitis suggests that homologous but not heterologous immunity is usuallv produced by one attack of either disease. In fact, the suggestion has been made that a previous attack of the one disease makes the individual more susceptible to the other. No explanation is forthcoming for the results of Oliphant's experiments in cross-immunity unless he had by chance selected 10 individuals who were not susceptible to infective hepatitis.
There is at present no test which will detect the presence of the icterogenic agent in a suspected serum except observation of the result of injection of the serum into man.
Therefore it is desirable to obtain some method of routine treatment of all sera which will inactivate the agent, if it is present in them, without destroying the essential properties of the serum. As can be seen in Table III , the agent is extremely resistant to heat at the temperature usually used for inactivation. The effect of higher temperatures has not been tested, but most sera will coagulate when heated above 60'C. Phenol in a concentration of 0.25% has also failed to inactivate the agent. Several experiments carried out by Oliphant suggested that the agent could be inactivated by ultraviolet light, but experiments by MacCallum et a.l. indicated that difficulties might. arise in determining the suitable energy to be used and the duration of exposure. In their first experiment the supposedly suitable. exposure failed to inactivate. In the second experiment the irradiation may have been effective, but when the serum was examined electrophoretically by Dr. R. A. Kekwick it was found that gross changes had occurred in the proteins. A very small residue of probably unchanged gamma globulin was detectable. Since the immune bodies in convalescent serum appear to be associated with the gamma globulin fraction this serum had been rendered useless for such a purpose. Even so, of the 10 recipients of this serum, one became jaundiced twenty-seven days after inoculation.
It has been suggested that very large pools would be safe because there would be sufficient immune bodies to neutralize any agent present. That such an event may occur has been shown by Oliphant, who inoculated a commercial pool of serum which contained serum of an individual taken four days before he became jaundiced (the total number of contributors to the pool was not stated). The jaundiced donor in this case was presumably suffering from infective hepatitis. This pool failed to produce hepatitis when injected subcutaneously or intravenously. Since the probability of neutralization occurring is unpredictable, this method does not seem safe. Though impracticable in wartime, the safest procedure would seem to be to process sera individually or at most small pools of two or three sera, thus limiting the number of recipients at risk if an icterogenic agent is present. If some idea could be obtained of the number of units of the agent that are neutralized by a given quantity of immune gamma globulin, the latter might be added to all pools as a routine.
SUMMARY
The available evidence suggests that the agent responsible for most cases of homologous serum hepatitis is not the same as that causing naturally occurring infective hepatitis.
The agent will pass through the usual filters which retain bacteria, but its actual size has not been determined. It is extremely resistant to heat and disinfectants, and no satisfactory method for the routine treatment of serum is known a present.
